Unique small RNA modifications in Alzheimer's disease
Human post-mortem brain samples from Alzheimer's disease (AD) and control individuals were processed for small RNA-sequencing followed by comparative analyses Overall design: Small RNA sequencing (15-45 nt) were performed for human post-mortem brain samples (prefrontal cortex) from AD patient and control individuals.